UBS Group AG - ERYTECH PHARMA ownership

ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 10 filers reported holding ERYTECH PHARMA in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ERYTECH PHARMA
ValueSharesWeighting
Q1 2023$539
-65.6%
550
-88.4%
0.00%
Q4 2022$1,569
-21.6%
4,755
+10.1%
0.00%
Q3 2022$2,000
-80.0%
4,320
-50.4%
0.00%
Q2 2022$10,000
+25.0%
8,711
+143.1%
0.00%
Q4 2021$8,000
-27.3%
3,583
+187.6%
0.00%
Q3 2018$11,000
-15.4%
1,246
+6.0%
0.00%
Q2 2018$13,000
-48.0%
1,176
-0.1%
0.00%
Q1 2018$25,000
-30.6%
1,177
-28.1%
0.00%
Q4 2017$36,0001,6370.00%
Other shareholders
ERYTECH PHARMA shareholders Q4 2021
NameSharesValueWeighting ↓
BVF INC/IL 1,314,656$690,0000.03%
Vanguard Personalized Indexing Management, LLC 59,839$33,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,005$6,0000.00%
Asset Dedication, LLC 4,000$2,0000.00%
Ikarian Capital, LLC 3,019$2,0000.00%
UBS Group AG 4,320$2,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 10,590$6,0000.00%
Mariner, LLC 59,472$33,0000.00%
Citadel Advisors 18,181$10,0000.00%
View complete list of ERYTECH PHARMA shareholders